Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period ...
Fintel on MSN2d
Redburn Atlantic Upgrades DexCom (DXCM)Fintel reports that on February 3, 2025, Redburn Atlantic upgraded their outlook for DexCom (NasdaqGS:DXCM) from Neutral to ...
The bull market of the past year or more has reinvigorated investors' interest across a range of industries, and the ...
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...
Many DexCom, Inc. ( NASDAQ:DXCM ) insiders ditched their stock over the past year, which may be of interest to ...
American Diversified Holdings Corporation (OTC Pink: ADHC) pleased to provide the shareholder community an update on the ...
Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ...
Redburn Atlantic upgraded DexCom (DXCM) to Buy from Neutral with a price target of $115, up from $85. The company is positioned to benefit from ...
Shares of DexCom Inc. DXCM rose 1.51% to $88.78 Wednesday, on what proved to be an all-around great trading session for the ...
Oura’s latest Ring is the best smart ring on the market. But its range of functions remains limited by its size and the fact ...
DexCom Inc. closed 38.30% below its 52-week high of $142.00, which the company achieved on March 26th.
DexCom (NASDAQ:DXCM) shares received an optimistic update from Redburn-Atlantic, with analyst Issie Kirby (NYSE:KEX) upgrading the stock from Neutral to Buy and increasing the price target to $115 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback